Related Experiment Video
Updated: Nov 7, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Refining genotype-phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1
Kathrin Burgmaier1, Leonie Brinker2, Florian Erger3
1Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany.
Insights
New findings reveal specific PKHD1 gene regions linked to Autosomal recessive polycystic kidney disease (ARPKD) severity. Understanding these genotype-phenotype correlations aids personalized ARPKD patient care.
Area of Science:
- Genetics
- Pediatric Nephrology
- Molecular Medicine
Background:
- Autosomal recessive polycystic kidney disease (ARPKD) is a severe early childhood condition.
- Fibrocystic kidney and liver changes characterize ARPKD, primarily caused by PKHD1 gene variants.
- Clinical heterogeneity in ARPKD is not fully understood, with limited genotype-phenotype data.
Purpose of the Study:
- To identify novel genotype-phenotype correlations in ARPKD patients.
- To analyze deep clinical data from a large ARPKD cohort.
- To improve understanding of ARPKD heterogeneity in children and adolescents.
Main Methods:
- Observational study of 304 ARPKD patients from two independent cohorts.
- Analysis of deep clinical datasets.
- Correlation of PKHD1 gene variant locations with clinical outcomes.
Main Results:
- Biallelic null variants in PKHD1 are frequently associated with severe ARPKD.
- Specific missense variant regions in fibrocystin correlate with kidney and liver outcomes.
- Variants in PKHD1 amino acids 709-1837 linked to reduced chronic kidney failure risk.
- Variants in amino acids 1838-2624 associated with better liver outcomes, while 2625-4074 linked to poorer outcomes.
Conclusions:
- Novel genotype-phenotype correlations in pediatric ARPKD are identified.
- The affected region within the PKHD1 gene influences ARPKD phenotype.
- Findings support more precise genetic counseling and personalized treatment strategies for ARPKD.
Abstract:
Autosomal recessive polycystic kidney disease (ARPKD) is a severe disease of early childhood that is clinically characterized by fibrocystic changes of the kidneys and the liver. The main cause of ARPKD are variants in the PKHD1 gene encoding the large transmembrane protein fibrocystin. The mechanisms underlying the observed clinical heterogeneity in ARPKD remain incompletely understood, partly due to the fact that genotype-phenotype correlations have been limited to the association of biallelic null variants in PKHD1 with the most severe phenotypes. In this observational study we analyzed a deep clinical dataset of 304 patients with ARPKD from two independent cohorts and identified novel genotype-phenotype correlations during childhood and adolescence. Biallelic null variants frequently show severe courses. Additionally, our data suggest that the affected region in PKHD1 is important in determining the phenotype. Patients with two missense variants affecting amino acids 709-1837 of fibrocystin or a missense variant in this region and a null variant less frequently developed chronic kidney failure, and patients with missense variants affecting amino acids 1838-2624 showed better hepatic outcome. Variants affecting amino acids 2625-4074 of fibrocystin were associated with poorer hepatic outcome. Thus, our data expand the understanding of genotype-phenotype correlations in pediatric ARPKD patients and can lay the foundation for more precise and personalized counselling and treatment approaches.
More Related Videos
Related Concept Videos
Pedigree Analysis
Genetic Lingo
Chronic Kidney Disease I: Introduction
Nephrons

